Inspira Technologies Oxy B.H.N. Ltd (IINN)

$0.60 +0.02 (3.47%)
Market Cap 7.32M
Revenue (ttm) 0.00
Net Income (ttm) -11.05M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 5.27
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 78,600
Avg Vol 687,926
Day's Range N/A - N/A
Shares Out 12.62M
Stochastic %K 82%
Beta 2.25
Analysts Sell
Price Target $5.00

Company Profile

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira...

Industry: Medical Devices
Sector: Healthcare
Phone: 972 4 623 0333
Address:
2 Ha-Tidhar St., Ra'anana, Israel
jranz10
jranz10 Mar. 3 at 2:02 AM
$IINN just get back to .80 and i’ll be happy 🙄
0 · Reply
JakBurton
JakBurton Mar. 2 at 9:06 PM
$IINN
0 · Reply
nothingsnew
nothingsnew Mar. 2 at 2:41 PM
$IINN
0 · Reply
jedledbetter
jedledbetter Mar. 2 at 2:32 PM
$IINN
0 · Reply
JakBurton
JakBurton Feb. 27 at 9:03 PM
$IINN
0 · Reply
nothingsnew
nothingsnew Feb. 27 at 3:59 PM
$IINN
0 · Reply
JakBurton
JakBurton Feb. 27 at 1:55 PM
$IINN
1 · Reply
THE_Perfusionist
THE_Perfusionist Feb. 27 at 1:28 PM
$IINN
0 · Reply
JakBurton
JakBurton Feb. 27 at 12:30 PM
$IINN Between the YA II and AGP offering that have been amended for merger use, the company took in $6549999 of which $6 million is now locked into this merger, the company burns $500,000 a month, I would expect news while we wait to keep the lights on hence the 2 million AGP ATM, JMO
0 · Reply
nothingsnew
nothingsnew Feb. 26 at 9:25 PM
$IINN they must want it at that price 🤔
0 · Reply
Latest News on IINN
Inspira Receives Nasdaq Notification Regarding Minimum Market Value Deficiency

Feb 25, 2026, 4:10 PM EST - 5 days ago

Inspira Receives Nasdaq Notification Regarding Minimum Market Value Deficiency

Inspira Expands U.S. Commercial Footprint: Deploys ART100 at a New Premier New York Academic Medical Center, Ranked Top 10 in New York State

Feb 18, 2026, 8:32 AM EST - 12 days ago

Inspira Expands U.S. Commercial Footprint: Deploys ART100 at a New Premier New York Academic Medical Center, Ranked Top 10 in New York State

Inspira Accelerates U.S. Commercial Strategy: FDA-Cleared ART100 Targets Market Adoption at AmSECT 2026 via Glo-Med Networks

Feb 17, 2026, 8:00 AM EST - 13 days ago

Inspira Accelerates U.S. Commercial Strategy: FDA-Cleared ART100 Targets Market Adoption at AmSECT 2026 via Glo-Med Networks

Inspira Technologies Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement

Feb 12, 2026, 4:01 PM EST - 18 days ago

Inspira Technologies Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement

Inspira Technologies Validates Next-Gen Standalone HYLA™ Blood Sensor with Clinical-Grade Accuracy, Targeting $48 Billion Heart-Lung Surgery Market

Feb 3, 2026, 9:22 AM EST - 27 days ago

Inspira Technologies Validates Next-Gen Standalone HYLA™ Blood Sensor with Clinical-Grade Accuracy, Targeting $48 Billion Heart-Lung Surgery Market

Inspira Advances to Final Governmental Budgetary Validation Procedures for Previously Announced Binding Purchase Orders

Jan 21, 2026, 8:50 AM EST - 5 weeks ago

Inspira Advances to Final Governmental Budgetary Validation Procedures for Previously Announced Binding Purchase Orders

CORRECTION – Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Investment of $15 Million into Inspira at $180 Million Valuation

Jan 5, 2026, 10:46 AM EST - 2 months ago

CORRECTION – Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Investment of $15 Million into Inspira at $180 Million Valuation

Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Concurrent $15 Million Investment at $180 Million Valuation

Jan 5, 2026, 9:30 AM EST - 2 months ago

Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Concurrent $15 Million Investment at $180 Million Valuation

Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones

Dec 23, 2025, 8:30 AM EST - 2 months ago

Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones

Inspira Announces $1.8 Million Registered Direct Offering Priced At-The-Market and Additional Equity Financing Agreement to Support Ongoing Commercial Execution

Dec 15, 2025, 8:30 AM EST - 2 months ago

Inspira Announces $1.8 Million Registered Direct Offering Priced At-The-Market and Additional Equity Financing Agreement to Support Ongoing Commercial Execution

Inspira Technologies Announces Strategic Leap in Lab Capabilities – Accelerating Next-Generation Diagnostics and Blood Technology

Dec 3, 2025, 8:43 AM EST - 3 months ago

Inspira Technologies Announces Strategic Leap in Lab Capabilities – Accelerating Next-Generation Diagnostics and Blood Technology

Inspira Completes Clinical Study for HYLA™ Blood Sensor - Ahead of Regulatory Submission

Nov 13, 2025, 9:00 AM EST - 3 months ago

Inspira Completes Clinical Study for HYLA™ Blood Sensor - Ahead of Regulatory Submission

Inspira Technologies Nears Final Regulatory Clearance for the ART100 in the UAE, Accelerating Gulf Region Expansion

Nov 6, 2025, 9:10 AM EST - 4 months ago

Inspira Technologies Nears Final Regulatory Clearance for the ART100 in the UAE, Accelerating Gulf Region Expansion

Inspira and Bites Form Strategic Alliance to Embed AI as a Core Standard Across Inspira's Global Ecosystem

Oct 22, 2025, 8:30 AM EDT - 4 months ago

Inspira and Bites Form Strategic Alliance to Embed AI as a Core Standard Across Inspira's Global Ecosystem

Inspira Appoints Former Johnson & Johnson Executive as VP of Global Sales and New Board Member from a Leading International Investment Firm

Oct 21, 2025, 9:05 AM EDT - 4 months ago

Inspira Appoints Former Johnson & Johnson Executive as VP of Global Sales and New Board Member from a Leading International Investment Firm

Inspira Technologies Reports First Half 2025 Financial Results and Issues Business Update

Oct 1, 2025, 8:00 AM EDT - 5 months ago

Inspira Technologies Reports First Half 2025 Financial Results and Issues Business Update

Inspira Announces 97.3% Accuracy Results for HYLA™ Blood Sensor, Advancing Toward FDA Submission for Clearance

Sep 11, 2025, 9:30 AM EDT - 6 months ago

Inspira Announces 97.3% Accuracy Results for HYLA™ Blood Sensor, Advancing Toward FDA Submission for Clearance

Inspira Receives U.S. Patent Approval for the ART500 Core Technology, Key Patent Positions the Company to Dominate $20 Billion Estimated Market

Aug 22, 2025, 8:45 AM EDT - 6 months ago

Inspira Receives U.S. Patent Approval for the ART500 Core Technology, Key Patent Positions the Company to Dominate $20 Billion Estimated Market

Inspira Clarifies Routine Nature of Registration Statement on Form F-3 Filing Performed Every Three Years

Aug 7, 2025, 9:44 AM EDT - 7 months ago

Inspira Clarifies Routine Nature of Registration Statement on Form F-3 Filing Performed Every Three Years

Inspira Activates U.S. Based Consulting Firm to Execute Transformational Initiatives

Jul 31, 2025, 9:15 AM EDT - 7 months ago

Inspira Activates U.S. Based Consulting Firm to Execute Transformational Initiatives

Inspira Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jul 18, 2025, 8:10 AM EDT - 8 months ago

Inspira Regains Compliance with Nasdaq Minimum Bid Price Requirement

Inspira Achieves All Key Objectives in Previously Announced Government Talks, Forging a Pathway to National Adoption and Global Scale-Up of the ART100

Jul 10, 2025, 9:25 AM EDT - 8 months ago

Inspira Achieves All Key Objectives in Previously Announced Government Talks, Forging a Pathway to National Adoption and Global Scale-Up of the ART100

Inspira in High-Level Government Talks to Advance National Integration of the ART100 and Establish a Global Distribution Framework

Jul 7, 2025, 8:50 AM EDT - 8 months ago

Inspira in High-Level Government Talks to Advance National Integration of the ART100 and Establish a Global Distribution Framework

Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase

Jul 2, 2025, 9:23 AM EDT - 8 months ago

Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase

Inspira's ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions

Jun 11, 2025, 9:10 AM EDT - 9 months ago

Inspira's ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions

CORRECTION - Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority

Jun 5, 2025, 11:15 AM EDT - 9 months ago

CORRECTION - Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority

Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority

Jun 5, 2025, 9:15 AM EDT - 9 months ago

Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority

Inspira Technologies Initiates Global Commercial Rollout of FDA-Cleared ART100 System

May 29, 2025, 9:15 AM EDT - 9 months ago

Inspira Technologies Initiates Global Commercial Rollout of FDA-Cleared ART100 System

INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients

May 7, 2025, 8:45 AM EDT - 10 months ago

INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients

Inspira Achieves above 99% Gas Exchange Efficiency in VORTX™ Technology In-Vivo Animal Testing

Apr 23, 2025, 8:00 AM EDT - 11 months ago

Inspira Achieves above 99% Gas Exchange Efficiency in VORTX™ Technology In-Vivo Animal Testing

Inspira Technologies Generates First Revenues from Deployment of INSPIRA ART100 Systems

Apr 15, 2025, 9:15 AM EDT - 11 months ago

Inspira Technologies Generates First Revenues from Deployment of INSPIRA ART100 Systems

Inspira Technologies Announces Successful Installation of INSPIRA ART100 Systems in Premier U.S. Hospital

Mar 25, 2025, 8:30 AM EDT - 1 year ago

Inspira Technologies Announces Successful Installation of INSPIRA ART100 Systems in Premier U.S. Hospital

Inspira Technologies' Innovative Life-Support System to be Showcased at AmSECT 63rd International Conference 2025 in San Diego

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Inspira Technologies' Innovative Life-Support System to be Showcased at AmSECT 63rd International Conference 2025 in San Diego

PESG Report: Inspira Technologies' AI-Powered Respiratory System Could Revolutionize Care for 20 Million Annual ICU Patients in Combined $25+ Billion Market

Mar 18, 2025, 1:17 PM EDT - 1 year ago

PESG Report: Inspira Technologies' AI-Powered Respiratory System Could Revolutionize Care for 20 Million Annual ICU Patients in Combined $25+ Billion Market

Inspira Technologies Releases CEO Update: Major Milestones Signal Next-Level Respiratory Care

Mar 14, 2025, 7:00 AM EDT - 1 year ago

Inspira Technologies Releases CEO Update: Major Milestones Signal Next-Level Respiratory Care

Inspira Technologies Receives Nasdaq Notification Regarding Minimum Bid Requirement

Mar 13, 2025, 4:30 PM EDT - 1 year ago

Inspira Technologies Receives Nasdaq Notification Regarding Minimum Bid Requirement

Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates

Mar 11, 2025, 8:30 AM EDT - 1 year ago

Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates

PESG Report: Inspira Technologies Breaks new Ground with Positive Clinical Data for AI-Powered Blood Sensor Exceeding Expectations

Mar 5, 2025, 8:46 AM EST - 1 year ago

PESG Report: Inspira Technologies Breaks new Ground with Positive Clinical Data for AI-Powered Blood Sensor Exceeding Expectations

Inspira Technologies Announces Positive Results from Clinical Study of HYLA Blood Sensor, Achieving 96% Accuracy

Mar 4, 2025, 8:30 AM EST - 1 year ago

Inspira Technologies Announces Positive Results from Clinical Study of HYLA Blood Sensor, Achieving 96% Accuracy

Inspira Achieves Positive Results of Above 95% For Preventing Bloodstream Infections

Feb 11, 2025, 7:00 AM EST - 1 year ago

Inspira Achieves Positive Results of Above 95% For Preventing Bloodstream Infections

PESG Report: Inspira Technologies Strengthens its AI-Powered Blood Sensor with new Capabilities, Intends to Share Clinical Findings Soon

Feb 6, 2025, 8:27 AM EST - 1 year ago

PESG Report: Inspira Technologies Strengthens its AI-Powered Blood Sensor with new Capabilities, Intends to Share Clinical Findings Soon

Inspira Technologies Integrates New Oxygenation Indicator into AI-Powered HYLA Blood Sensor

Feb 5, 2025, 8:30 AM EST - 1 year ago

Inspira Technologies Integrates New Oxygenation Indicator into AI-Powered HYLA Blood Sensor

Inspira™ Introduces Advanced Features for INSPIRA™ ART100, Further Amplifying User and System Support

Jan 27, 2025, 8:30 AM EST - 1 year ago

Inspira™ Introduces Advanced Features for INSPIRA™ ART100, Further Amplifying User and System Support

Inspira™ Technologies Prepares its First Life-Support Systems for Deployment at a Leading U.S. Hospital

Jan 22, 2025, 8:30 AM EST - 1 year ago

Inspira™ Technologies Prepares its First Life-Support Systems for Deployment at a Leading U.S. Hospital

Inspira™ Announces the Appointment of Tal Parnes as the New Chairman of the Board, Bringing Vast Experience in the Medical Technology and Pharmaceutical Sectors

Jan 21, 2025, 8:30 AM EST - 1 year ago

Inspira™ Announces the Appointment of Tal Parnes as the New Chairman of the Board, Bringing Vast Experience in the Medical Technology and Pharmaceutical Sectors

Inspira™ Technologies Collaborates With Zriha Medical To Launch Cutting-Edge Production Line

Jan 17, 2025, 8:30 AM EST - 1 year ago

Inspira™ Technologies Collaborates With Zriha Medical To Launch Cutting-Edge Production Line

Inspira™ Technologies Unveils Modular Configuration for Revolutionary VORTX™ Blood Oxygenation Delivery Technology

Jan 14, 2025, 8:30 AM EST - 1 year ago

Inspira™ Technologies Unveils Modular Configuration for Revolutionary VORTX™ Blood Oxygenation Delivery Technology

Inspira™ Preparing Production in Response to Spread of Respiratory Virus in China

Jan 10, 2025, 6:15 AM EST - 1 year ago

Inspira™ Preparing Production in Response to Spread of Respiratory Virus in China

Inspira™ Technologies Flagship Technology to be Showcased at Arab Health Expo 2025 in Dubai

Jan 7, 2025, 8:15 AM EST - 1 year ago

Inspira™ Technologies Flagship Technology to be Showcased at Arab Health Expo 2025 in Dubai

jranz10
jranz10 Mar. 3 at 2:02 AM
$IINN just get back to .80 and i’ll be happy 🙄
0 · Reply
JakBurton
JakBurton Mar. 2 at 9:06 PM
$IINN
0 · Reply
nothingsnew
nothingsnew Mar. 2 at 2:41 PM
$IINN
0 · Reply
jedledbetter
jedledbetter Mar. 2 at 2:32 PM
$IINN
0 · Reply
JakBurton
JakBurton Feb. 27 at 9:03 PM
$IINN
0 · Reply
nothingsnew
nothingsnew Feb. 27 at 3:59 PM
$IINN
0 · Reply
JakBurton
JakBurton Feb. 27 at 1:55 PM
$IINN
1 · Reply
THE_Perfusionist
THE_Perfusionist Feb. 27 at 1:28 PM
$IINN
0 · Reply
JakBurton
JakBurton Feb. 27 at 12:30 PM
$IINN Between the YA II and AGP offering that have been amended for merger use, the company took in $6549999 of which $6 million is now locked into this merger, the company burns $500,000 a month, I would expect news while we wait to keep the lights on hence the 2 million AGP ATM, JMO
0 · Reply
nothingsnew
nothingsnew Feb. 26 at 9:25 PM
$IINN they must want it at that price 🤔
0 · Reply
Kalambur2000
Kalambur2000 Feb. 26 at 5:35 PM
$IINN How long they can delay announcing the status of the 2025 POs and any potential POs for 2026, if any ?
1 · Reply
JakBurton
JakBurton Feb. 26 at 3:03 PM
$IINN Inspira's still been working regardless of merger and carve, expect the unexpected and be prepared, jmo
0 · Reply
nothingsnew
nothingsnew Feb. 26 at 2:54 PM
$IINN
0 · Reply
JakBurton
JakBurton Feb. 26 at 12:19 PM
$IINN
0 · Reply
JakBurton
JakBurton Feb. 26 at 1:38 AM
$IINN Super hyped, looks like merger is moving forward! CVR's will be liberating!
0 · Reply
IPOWarrior
IPOWarrior Feb. 25 at 10:11 PM
$IINN Update on the merger and proposed structure of the financing: https://www.sec.gov/Archives/edgar/data/1837493/000118518526000667/iinn6k022526.htm Main material point seems to be extending the timeline by 30 days, some points about where the initial $5M funding for legacy operations comes from, and aknowledgement of the SEC non-compliance notice. Not expecting a lot of PR while this is ongoing.
2 · Reply
nothingsnew
nothingsnew Feb. 25 at 9:29 PM
$IINN
0 · Reply
JohnFer
JohnFer Feb. 25 at 9:15 PM
$IINN can someone tell me what it means when there's a green number beside the price? I've only ever seen it red
0 · Reply
jedledbetter
jedledbetter Feb. 25 at 4:11 PM
$IINN
0 · Reply
JakBurton
JakBurton Feb. 25 at 2:45 PM
$IINN This is like a beach ball being held underwater, pressure is building!
1 · Reply
nothingsnew
nothingsnew Feb. 25 at 2:43 PM
$IINN
0 · Reply
JakBurton
JakBurton Feb. 25 at 12:17 PM
$IINN added, I think she's ready to go
1 · Reply